AKT1 and atopic eczema: Previous studies have confirmed that inhibiting the proteins on the PI3K-Akt signaling pathway can inhibit mast cell-mediated hypersensitivity [35], and four treatments may have the potential for anti-atopic dermatitis through this coupling pathway.